Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction

J Investig Allergol Clin Immunol. 2016;26(1):66-7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antimetabolites, Antineoplastic / immunology
  • Capecitabine / administration & dosage
  • Capecitabine / adverse effects*
  • Capecitabine / immunology
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • Desensitization, Immunologic / methods*
  • Drug Administration Schedule
  • Drug Eruptions / diagnosis
  • Drug Eruptions / immunology
  • Drug Eruptions / therapy*
  • Humans
  • Hypersensitivity, Delayed / diagnosis
  • Hypersensitivity, Delayed / immunology
  • Hypersensitivity, Delayed / therapy*
  • Immune Tolerance
  • Intradermal Tests
  • Male
  • Skin / drug effects*
  • Skin / immunology
  • Skin / pathology
  • Time Factors
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Capecitabine